跳至主要内容
临床试验/NCT05001152
NCT05001152已完成1 期

An Open-Label Taste Assessment of Ozanimod in Healthy Subjects

Bristol-Myers Squibb2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2021年9月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
7
试验地点
2
主要终点
Taste evaluation - Aromatic identity

研究概览

简要总结

The purpose of this study is to assess the taste characteristics of ozanimod formulations, alone and mixed, in order to develop a pediatric oral form of ozanimod.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women, between 25 and 80 years of age.
  • Participant is a qualified sensory panelist selected by Senopsys based on training and experience

排除标准

  • Participant has any history of any illness, medical condition, laboratory abnormality, or psychiatric illness that might confound the results of the study or places the panelist at unacceptable risk if he or she were to participate in the study.
  • Participant is a female that is pregnant, nursing, or planning to become pregnant during the study.
  • Other protocol-defined inclusion/exclusion criteria apply

研究组 & 干预措施

Ozanimod

Experimental

A maximum of 10 healthy adult participants (i.e., sensory panelists) will complete a maximum of 20 taste assessment days, with at least 4 panelists required to evaluate the taste characteristics of ozanimod on each taste assessment day.

干预措施: Ozanimod (Drug)

结局指标

主要结局

Taste evaluation - Aromatic identity

时间窗: Up to 6 months

Measured using the Flavor Profile method of descriptive sensory analysis

Taste evaluation - Amplitude

时间窗: Up to 6 months

Measured using the Flavor Profile method of descriptive sensory analysis

Taste evaluation - Off-notes

时间窗: Up to 6 months

Measured using the Flavor Profile method of descriptive sensory analysis

Taste evaluation - Aftertaste

时间窗: Up to 6 months

Measured using the Flavor Profile method of descriptive sensory analysis

次要结局

未报告次要终点

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验